Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MetfoRmin and Its Effects on Myocardial Dimension and Left Ventricular Hypertrophy in Normotensive Patients With Coronary Artery Disease

NCT02226510 is registered in ClinicalTrials.gov with University of Dundee as lead sponsor.

NCT NCT02226510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02226510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MetfoRmin and Its Effects on Myocardial Dimension and Left Ventricular Hypertrophy in Normotensive Patients With Coronary Artery Disease
Lead sponsor
University of Dundee
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2015
Completion date
December 31, 2017
Enrollment
68 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, insulin resistance, left ventricular hypertrophy, prediabetes